Skip to main content
Log in

Thyroid Hemorrhage Causing Airway Obstruction After Intravenous Thrombolysis for Acute Ischemic Stroke

  • Practical Pearl
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

There are several life-threatening complications associated with intravenous thrombolysis after acute ischemic stroke such as symptomatic intracerebral hemorrhage, orolingual angioedema, or less frequent, bleedings of the mucosa or ecchymosis. Aside from these known critical incidents, rare and unfamiliar complications may be even more challenging, as they are unexpected and may mimic events that appear more frequently. We report a rare and unusual acute complication of intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) (0.9 mg/kg) administered for acute ischemic stroke.

Methods

Medical records, radiologic imaging, and pathologic specimens were reviewed.

Results

A 86-year-old woman developed acute respiratory failure 20 h after thrombolysis with suspected angioedema triggered by intravenous rt-PA. The inspiratory stridor and dyspnea were unresponsive to bronchodilators, corticosteroids, and inhaled adrenaline. After endotracheal intubation, laryngoscopy showed no significant supraglottic narrowing. Thyroidal sonography and cervical computed tomography revealed a thyroidal mass causing a tracheal and vascular compression compatible with thyroidal hemorrhage. Sonography showed a nodular goiter of the right thyroid gland. A total thyroidectomy was performed and histologic analysis confirmed a hemorrhage of the right thyroidal lobe.

Conclusions

Acute airway obstruction with respiratory failure due to thyroidal hemorrhage after intravenous thrombolysis is an important life-threatening complication, mimicking an anaphylactic reaction or a more frequent orolingual angioedema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dhand A, Nakagawa K, Nagpal S, Gelfand JM, Kim AS, Smith WS, et al. Cardiac rupture after intravenous t-PA administration in acute ischemic stroke. Neurocrit Care. 2010;13:261–2.

    Article  CAS  PubMed  Google Scholar 

  2. Kellert L, Rocco A, Sykora M, Hacke W, Ringleb PA. Frequency of increased blood pressure levels during systemic thrombolysis and risk of intracerebral hemorrhage. Stroke. 2011;42:1702–6.

    Article  PubMed  Google Scholar 

  3. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005;46:56–60.

    Article  PubMed  Google Scholar 

  4. Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330–5.

    Article  CAS  PubMed  Google Scholar 

  5. Libman R, Kwiakowski T, Lyden P, Grotta JC, Tilley BC, Fagen SC, et al. Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis. 2005;14:50–4.

    Article  PubMed  Google Scholar 

  6. Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation. 1998;98:1376–82.

    Article  CAS  PubMed  Google Scholar 

  7. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18–22.

    Article  CAS  PubMed  Google Scholar 

  8. Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke. 1999;30:1326–32.

    Article  CAS  PubMed  Google Scholar 

  9. Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology. 2003;60:1525–7.

    Article  CAS  PubMed  Google Scholar 

  10. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307–12.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Onal IK, Dagdelen S, Atmaca A, Karadag O, Adalar N. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis. Endocr Pract. 2006;12:299–301.

    Article  PubMed  Google Scholar 

  12. Tsilchorozidou T, Vagropoulos I, Karagianidou C, Grigoriadis N. Huge intrathyroidal hematoma causing airway obstruction: a multidisciplinary challenge. Thyroid. 2006;16:795–9.

    Article  PubMed  Google Scholar 

  13. Chia PL. Thyroid hemorrhage after thrombolytic therapy for acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2008;9:935–6.

    Article  Google Scholar 

Download references

Acknowledgments

Dr. Raoul Sutter is supported by the Research Funds of the University of Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation.

Conflict of interest

Dr. Raoul Sutter, Dr. Gianmarco M. Balestra, Dr. Elisabeth Bruder, and Dr. Mandy Weissenburg have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianmarco M. Balestra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sutter, R., Bruder, E., Weissenburg, M. et al. Thyroid Hemorrhage Causing Airway Obstruction After Intravenous Thrombolysis for Acute Ischemic Stroke. Neurocrit Care 19, 381–384 (2013). https://doi.org/10.1007/s12028-013-9889-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-013-9889-z

Keywords

Navigation